Toxicology and Pharmacology

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Jan 2015

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Thailand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Thailand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 116 pages

BMI View: Thailand is a moderately attractive pharmaceutical industry for multinationals. On the positive side, rewards are potentially considerable, given the country’s epidemiological profile and the growing population numbers. However, the government’s stance on compulsory licences and regulatory ...

Industries: Drug and Medication | Countries: Thailand

South Korea Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

South Korea Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 142 pages

BMI View: Unlike some observers, BMI classes South Korea as a developed country and this is underpinned by the balanced risk/reward profile of its pharmaceutical industry . Negative attributes include the sub-standard enforcement of intellectual property rights, industry access issues and price cuts. ...

Industries: Pharmaceutical | Countries: South Korea

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 104 pages

BMI View: The Kenyan pharmaceuticals and healthcare industry presents significant revenue-earning opportunities for drug firms . Growth in the segment will be boosted by strong demographics, increased healthcare needs, longer life expectancy, rising healthcare spending in the public and private segments ...

Industries: Pharmaceutical | Countries: Kenya

Guangdong Jiaying Pharmaceutical Co., Limited

Guangdong Jiaying Pharmaceutical Co., Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 55 pages

A textual analysis of the financial results for Guangdong Jiaying Pharmaceutical Co., Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security ...

Industries: Pharmaceutical | Countries: China

Zhuzhou Qianjin Pharmaceutical Co., Ltd.

Zhuzhou Qianjin Pharmaceutical Co., Ltd.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 56 pages

A textual analysis of the financial results for Zhuzhou Qianjin Pharmaceutical Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Shanghai No. 1 Pharmaceutical Company Limited

Shanghai No. 1 Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 55 pages

A textual analysis of the financial results for Shanghai No. 1 Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security ...

Industries: Pharmaceutical

Xiangxue Pharmaceutical Co Ltd

Xiangxue Pharmaceutical Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 55 pages

A textual analysis of the financial results for Xiangxue Pharmaceutical Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical

Shanghai Fosun Pharmaceutical (Group) Company Limited

Shanghai Fosun Pharmaceutical (Group) Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 56 pages

A textual analysis of the financial results for Shanghai Fosun Pharmaceutical (Group) Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and ...

Industries: Pharmaceutical

Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 56 pages

A textual analysis of the financial results for Jiangsu Hengrui Medicine Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Drug and Medication

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.